Concepedia

M. Skalland

MS

13

Publications

704

Citations

12

H-Index

2017

Active since

Affiliations

University of Washington(Current)

Seattle Children's Hospital

Johns Hopkins University

Cystic Fibrosis Foundation

University of Colorado Denver

M. Skalland is an author at University of Washington specializing in medicine, pulmonary fibrosis, and pulmonary medicine.

ORCID

Top concepts

Publications per year

2017–2023

13

Publications

13

Pharmacologic improvement of CFTR function rapidly decreases sputum pathogen density, but lung infections generally persist

David P. Nichols, Sarah J. Morgan, M. Skalland et al. · Journal of Clinical Investigation · 2023 · 181 citations · Full text

Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials

Nicole Mayer-Hamblett, Félix Ratjen, Renee Russell et al. · The Lancet Respiratory Medicine · 2022 · 116 citations · Full text

, , +1

Elexacaftor/tezacaftor/ivacaftor and gastrointestinal outcomes in cystic fibrosis: Report of promise-GI

Sarah Jane Schwarzenberg, Phuong T. Vu, M. Skalland et al. · Journal of Cystic Fibrosis · 2022 · 113 citations · Full text

, , +2

Azithromycin for Early <i>Pseudomonas</i> Infection in Cystic Fibrosis. The OPTIMIZE Randomized Trial

Nicole Mayer-Hamblett, George Retsch‐Bogart, Margaret Kloster et al. · American Journal of Respiratory and Critical Care Medicine · 2018 · 96 citations · Full text

Pulmonary Outcomes Associated with Long-Term Azithromycin Therapy in Cystic Fibrosis

Dave P. Nichols, Katherine Odem‐Davis, Jonathan D. Cogen et al. · American Journal of Respiratory and Critical Care Medicine · 2019 · 64 citations · Full text

Rows per page

1–5 of 13